Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1958 3
1959 1
1960 1
1961 1
1962 4
1963 2
1964 14
1965 5
1966 4
1967 4
1968 6
1969 3
1970 2
1971 2
1972 2
1974 5
1975 5
1976 2
1977 4
1978 5
1979 2
1980 6
1981 8
1982 10
1983 10
1984 16
1985 14
1986 10
1987 22
1988 22
1989 17
1990 32
1991 21
1992 33
1993 35
1994 37
1995 37
1996 39
1997 48
1998 42
1999 54
2000 52
2001 58
2002 84
2003 62
2004 88
2005 78
2006 68
2007 82
2008 96
2009 72
2010 80
2011 83
2012 83
2013 72
2014 90
2015 77
2016 90
2017 78
2018 78
2019 79
2020 108
2021 113
2022 47
Text availability
Article attribute
Article type
Publication date

Search Results

2,202 results
Results by year
Filters applied: . Clear all
Page 1
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1.
Ogitani Y, Aida T, Hagihara K, Yamaguchi J, Ishii C, Harada N, Soma M, Okamoto H, Oitate M, Arakawa S, Hirai T, Atsumi R, Nakada T, Hayakawa I, Abe Y, Agatsuma T. Ogitani Y, et al. Among authors: harada n. Clin Cancer Res. 2016 Oct 15;22(20):5097-5108. doi: 10.1158/1078-0432.CCR-15-2822. Epub 2016 Mar 29. Clin Cancer Res. 2016. PMID: 27026201
Engineering hybrid exosomes by membrane fusion with liposomes.
Sato YT, Umezaki K, Sawada S, Mukai SA, Sasaki Y, Harada N, Shiku H, Akiyoshi K. Sato YT, et al. Among authors: harada n. Sci Rep. 2016 Feb 25;6:21933. doi: 10.1038/srep21933. Sci Rep. 2016. PMID: 26911358 Free PMC article.
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance.
Muraoka D, Seo N, Hayashi T, Tahara Y, Fujii K, Tawara I, Miyahara Y, Okamori K, Yagita H, Imoto S, Yamaguchi R, Komura M, Miyano S, Goto M, Sawada SI, Asai A, Ikeda H, Akiyoshi K, Harada N, Shiku H. Muraoka D, et al. Among authors: harada n. J Clin Invest. 2019 Mar 1;129(3):1278-1294. doi: 10.1172/JCI97642. Epub 2019 Feb 11. J Clin Invest. 2019. PMID: 30628894 Free PMC article.
[Moonlighting proteins].
Harada N, Mitani T, Yamaji R. Harada N, et al. Seikagaku. 2015 Jun;87(3):279-85. Seikagaku. 2015. PMID: 26571591 Review. Japanese. No abstract available.
Impact of Capicua on Pancreatic Cancer Progression.
Yoshiya S, Itoh S, Yoshizumi T, Yugawa K, Kurihara T, Toshima T, Harada N, Hashisako M, Yonemasu H, Fukuzawa K, Oda Y, Mori M. Yoshiya S, et al. Among authors: harada n. Ann Surg Oncol. 2021 Jun;28(6):3198-3207. doi: 10.1245/s10434-020-09339-z. Epub 2020 Nov 20. Ann Surg Oncol. 2021. PMID: 33216264
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Hiki M, Tabe Y, Ai T, Matsue Y, Harada N, Sugimoto K, Matsushita Y, Matsushita M, Wakita M, Misawa S, Idei M, Miida T, Tamura N, Takahashi K, Naito T. Hiki M, et al. Among authors: harada n. PLoS One. 2021 Apr 6;16(4):e0249449. doi: 10.1371/journal.pone.0249449. eCollection 2021. PLoS One. 2021. PMID: 33822809 Free PMC article. Clinical Trial.
[Once-weekly DPP-4 inhibitor].
Harada N, Inagaki N. Harada N, et al. Nihon Rinsho. 2015 Dec;73(12):2096-102. Nihon Rinsho. 2015. PMID: 26666159 Japanese.
2,202 results